News zur COGENT BIOSCIENCES AKTIE ✓ und aktueller Realtime-Aktienkurs ✓ $1000 Invested In Cogent Biosciences 5 Years Ago Would Be Worth This Much Today ...

A case report highlights an instance of indolent SM with gastrointestinal involvement that was initially misdiagnosed as Crohn's disease.

Systemic mastocytosis should be considered in patients with refractory ascites once cirrhosis and malignancy have been ruled ...

Cogent Biosciences, Inc. (NASDAQ:COGT) has moved from proving bezuclastinib’s clinical activity to seeking regulatory ...

AMERICANS with 314 health conditions are able to get their Social Security checks delivered faster. The Social Security ...

Chinese hematologists report the first documented case of a single patient simultaneously harboring advanced systemic ...

All the Latest Game Footage and Images from Systemic War SYSTEMIC WAR is a next-generation strategy game that fuses grand geopolitical decision-making with real-time tactical combat. Command entire ...

A single-center study of 58 children with cutaneous mastocytosis shows that clinical subtype and standardized skin scoring ...

SM-AML can remain occult until cytoreduction shows MC proliferation, highlighting a potential role for SM evaluation in KIT-positive AML.

The FDA has accepted a New Drug Application for the oral KIT D816V inhibitor bezuclastinib for advanced systemic mastocytosis, with a PDUFA action date of June 29, 2027. The Food and Drug ...

For many people, getting diagnosed with indolent systemic mastocytosis (ISM) finally puts a name to years of confusing symptoms. ISM is a blood disorder in which mast cells—immune cells found ...

For over a decade, Ruth has written for multiple outlets providing patient education, including Health. She has written for health student education companies, collaborating on an anatomy textbook ...